Show simple item record

dc.contributor.authorGunduz, Huseyin
dc.contributor.authorSahin, Sait Emir
dc.contributor.authorCakar, Mehmet Akif
dc.contributor.authorKilic, Harun
dc.contributor.authorAgac, Mustafa Tarik
dc.contributor.authorAkdemir, Ramazan
dc.contributor.authorTatli, Ersan
dc.contributor.authorUreyen, Cagin Mustafa
dc.contributor.authorCosansu, Kahraman
dc.contributor.authorVural, Mustafa Gokhan
dc.date.accessioned2021-03-06T10:07:11Z
dc.date.available2021-03-06T10:07:11Z
dc.date.issued2020
dc.identifier.citationUreyen C. M. , Cosansu K., Vural M. G. , Sahin S. E. , Cakar M. A. , Kilic H., Agac M. T. , Gunduz H., Akdemir R., Tatli E., "Percutaneous Coronary Intervention for Chronic Total Occlusion versus Percutaneous Coronary Intervention for Non-Complex Coronary Lesions: Is There a Different Impact on Thyroid Function?", MEDICAL PRINCIPLES AND PRACTICE, cilt.29, ss.188-194, 2020
dc.identifier.issn1011-7571
dc.identifier.othervv_1032021
dc.identifier.otherav_e8cdea6d-2b77-4c97-9fd6-19786216f19a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/152984
dc.identifier.urihttps://doi.org/10.1159/000503553
dc.description.abstractObjective: This study assessed whether high levels of iodide administered during percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) differentially influenced thyroid function compared to PCI for non-complex coronary lesions. Subjects and Methods: A total of 615 patients were enrolled in the study; 205 underwent elective PCI for CTO lesions (Group I) and 410 underwent elective PCI for non-complex lesions including non-CTO, non-bifurcation, non-calcified, and non-tortuous lesions (Group II). Patients were monitored for development of incidental thyroid dysfunction between 1 and 6 months after PCI. Results: The patients in Group I were administered a median of 255 mL of contrast medium during PCI for CTO; a median of 80 mL was administered to the patients in Group II during non-complex PCI (p =0.001). Ten (5.4%) of the 186 euthyroid patients in Group I and 19 (5%) of the 379 eu-thyroid patients in Group II developed subclinical hyper-thyroidism (p = 0.854). However, 7 (50%) of the 14 subclinical hyperthyroid patients in Group I and only 3 (12%) of the 25 subclinical hyperthyroid patients in Group II developed overt hyperthyroidism (p = 0.019). Conclusion: In euthyroid patients, PCI for coronary CTO lesions did not increase the risk for subclinical hyperthyroidism when compared to PCI for non-complex coronary lesions. However, in patients with subclinical hyperthyroidism at baseline, PCI for coronary CTO lesions significantly increased the development of overt hyperthyroidism when compared to PCI for non-complex coronary lesions.
dc.language.isoeng
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.titlePercutaneous Coronary Intervention for Chronic Total Occlusion versus Percutaneous Coronary Intervention for Non-Complex Coronary Lesions: Is There a Different Impact on Thyroid Function?
dc.typeMakale
dc.relation.journalMEDICAL PRINCIPLES AND PRACTICE
dc.contributor.departmentAntalya Training & Research Hospital , ,
dc.identifier.volume29
dc.identifier.issue2
dc.identifier.startpage188
dc.identifier.endpage194
dc.contributor.firstauthorID2277449


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record